DEA to Begin Collecting Public Comments on Marijuana Rescheduling Tomorrow, May 21

The DEA released its proposed rules for the rescheduling of marijuana last week. These rules will be officially published in the Federal Register tomorrow, initiating the legally required 60-day public comment period.

According to the notice published by the DEA, the agency plans to reschedule marijuana, moving it from its current Schedule I status to a Schedule III classification. This announcement coincided with a social media video from President Biden and Vice President Harris announcing and praising the move.

The DEA has confirmed that the notice will be published in the Federal Register tomorrow, May 21, 2024. This publication will kick off the legally required 60-day public comment period, allowing individuals and organizations to provide remarks and feedback on the proposed change. The proposed change is currently listed on the Federal Register’s website with the disclaimer, “This document is unpublished. It is scheduled to be published on 05/21/2024.”

After the public comment period, the DEA will review all submissions to assess public sentiment and gather additional evidence. This process will culminate in a final hearing and the issuance of a final ruling. Based on the current timeline, marijuana is expected to be officially moved to Schedule III sometime in August.

For a look at the 10 biggest implications of marijuana being moved to Schedule III, click here.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales

Study: Betel Leaf and CBD Formulations Show Strong Antibacterial Activity Against Drug-Resistant Canine Skin Infections

Study: Betel Leaf and CBD Formulations Show Strong Antibacterial Activity Against Drug-Resistant Canine Skin Infections

Five Former U.S. Attorneys Say They Never Received Biden-Era Memo on Simple Cannabis Possession That Wyoming’s Top Prosecutor Claims Existed

Five Former U.S. Attorneys Say They Never Received Biden-Era Memo on Simple Cannabis Possession That Wyoming’s Top Prosecutor Claims Existed